Base case results
| Strategies | Health Care Costs | Effectiveness (QALY) | Difference | ICERa ($/QALY) | Dominance | |
|---|---|---|---|---|---|---|
| Costs | Effectiveness | |||||
| PET + MEG | $95,612 | 16.30 | – | – | ||
| SPECT + MEG | $95,824 | 16.28 | $212b | −0.0241b | – | Dominated |
| PET + SPECT | $96,532 | 16.36 | $920b | 0.0543b | $16,937c | Ext. Dominated |
| SPECT | $97,479 | 16.45 | $1867b | 0.1443b | $12,934c | |
| MEG | $97,499 | 16.42 | $21 | −0.0238d | – | Dominated |
| PET | $97,623 | 16.44 | $144 | −0.0121d | – | Dominated |
Note:— – indicates XXX; Ext., extended.
↵a The results of incremental effectiveness and ICER may not show as the calculated value based on the “Effectiveness” column due to round-up.
↵b The result of incremental cost and incremental effectiveness was compared with strategy 1—PET+MEG.
↵c The ICER was calculated when the strategies were compared with strategy 1—PET+MEG.
↵d The results of incremental effectiveness were compared with strategy 4—SPECT.